Literature DB >> 8508432

Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas.

H Matsumoto1, H Muramatsu, T Shimotakahara, M Yanagi, H Nishijima, N Mitani, K Baba, T Muramatsu, H Shimazu.   

Abstract

METHODS. The expression of ABH blood group carbohydrate antigens was examined histochemically in tumors and adjacent nontumorous tissues of 89 cases of human lung carcinoma in which nontumorous tissues expressed blood group carbohydrate antigens compatible with the erythrocyte blood group types. RESULTS AND CONCLUSIONS. Loss of ABH blood group antigens in lung carcinomas correlated with their metastatic potential, especially with the recurrence of hematogenous metastasis. Consequently, patients with tumors that retained compatible ABH blood group antigens showed a better prognosis than patients with tumors of altered antigenic profiles. The loss of blood group B antigen more significantly affected both the hematogenous metastasis and prognosis than that of A and H antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508432     DOI: 10.1002/1097-0142(19930701)72:1<75::aid-cncr2820720116>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

Review 2.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Epithelial Expression of Human ABO Blood Group Genes Is Dependent upon a Downstream Regulatory Element Functioning through an Epithelial Cell-specific Transcription Factor, Elf5.

Authors:  Rie Sano; Tamiko Nakajima; Yoichiro Takahashi; Rieko Kubo; Momoko Kobayashi; Keiko Takahashi; Haruo Takeshita; Kenichi Ogasawara; Yoshihiko Kominato
Journal:  J Biol Chem       Date:  2016-09-01       Impact factor: 5.157

4.  Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.

Authors:  Chunwoo Lee; Dalsan You; Mooyoung Sohn; In Gab Jeong; Cheryn Song; Taekmin Kwon; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

5.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.

Authors:  T Petretti; W Kemmner; B Schulze; P M Schlag
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.

Authors:  Allison B Weisbrod; David J Liewehr; Seth M Steinberg; Erin E Patterson; Steven K Libutti; W Marston Linehan; Naris Nilubol; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-02-16       Impact factor: 5.344

7.  Cell type-dependent alterations of binding of synthetic blood group antigen-related oligosaccharides in lung cancer.

Authors:  K Kayser; N V Bovin; T V Zemlyanukhina; S Donaldo-Jacinto; J Koopmann; H J Gabius
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

8.  Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.

Authors:  Allison B Weisbrod; Naris Nilubol; Lee S Weinstein; William F Simonds; Steven K Libutti; Robert T Jensen; Stephen J Marx; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2012-10-23       Impact factor: 5.958

9.  ABO blood group and incidence of skin cancer.

Authors:  Jing Xie; Abrar A Qureshi; Yunhui Li; Jiali Han
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

10.  DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients.

Authors:  Tina Bianco-Miotto; Damian J Hussey; Tanya K Day; Denise S O'Keefe; Alexander Dobrovic
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.